![](https://investorshub.advfn.com/uicon/243166.png?cb=1526922418)
Monday, December 18, 2017 6:03:57 PM
Endopat: $27K per unit
LXGTF HS: under $1K (we think based on the company's own comparisons)
EndoPAT: Facility based with a trained technician needed.
LXGTF HS: Consumer can operate without special training required
EndoPAT: Test time 15 min, plus waiting at clinic
LXGTF HS: Test time 5min, consumer can test themselves any time they wish.
EndoPAT: Only tests small vessels
LXGTF HS: Tests larger arteries.
EndoPAT: Accurate
LXGTF HS: Shown to be 5 times more sensitive in early testing
CLEAR ADVANTAGE: LXGTF HEARTSENTRY
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM